2. Academic Validation
  3. Synthesis of a Complex and Highly Potent PCSK9 Inhibitor

Synthesis of a Complex and Highly Potent PCSK9 Inhibitor

  • Org Lett. 2023 Jul 14;25(27):5001-5005. doi: 10.1021/acs.orglett.3c01635.
Jeffrey T Kuethe 1,  Joshua Lee 1,  David Thaisrivongs 1,  Nobuyoshi Yasuda 1,  Scott R Pollack 1,  Joseph Leone 1,  Jimmy DaSilva 1,  Mirlinda Biba 1,  Fuh-Rong Tsay 1,  Erik L Regalado 1,  Ji Qi 1,  Hongming Li 1,  Guilherme Dal Poggetto 1,  Ryan Cohen 1
Affiliations

Affiliation

  • 1 Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
PMID: 37382389 DOI: 10.1021/acs.orglett.3c01635
Abstract

The solution-based gram-scale synthesis of complex and highly potent proprotein convertase subtilisin-like/kexin type 9 (PCSK9) inhibitor 1 is presented. Construction of Northern fragment 2, followed by stepwise installation of Eastern 3, Southern 4, and Western 5 fragments, provided macrocyclic precursor 19. This intermediate was cross-linked via an intramolecular azide-alkyne click reaction, which preceded macrolactamization to afford the core framework of compound 1. Finally, coupling with poly(ethylene glycol) side-chain-based 6 gave the PCSK9 Inhibitor 1.

Figures
Products